Management of Symptomatic Bradycardia

Diagnosis and Initial Management

The American College of Cardiology recommends immediately evaluating and treating reversible causes of symptomatic bradycardia, which is a Class I recommendation, and takes absolute priority over any other intervention including pacemaker placement 1, 2
The American Heart Association suggests that symptomatic bradycardia requires urgent evaluation for symptoms including syncope, presyncope, lightheadedness, dyspnea on exertion, chronic fatigue, or altered mental status 5, 6
The gold standard for diagnosis is temporal correlation between symptoms and documented bradycardia, and symptoms without bradycardia do not warrant pacing 5, 6

The American College of Cardiology recommends maintaining a patent airway, assisting breathing, and providing supplementary oxygen if hypoxemic in patients with symptomatic bradycardia 7
Atropine 0.5 mg IV every 3-5 minutes up to a maximum of 3 mg is reasonable for symptomatic bradycardia, which is a Class IIa recommendation 6

The American Heart Association suggests aggressively investigating reversible causes, including medications such as beta-blockers, non-dihydropyridine calcium channel blockers, and digoxin 1, 5
The American College of Cardiology recommends withdrawing the offending drug or reducing the dosage, and switching beta-blocker to ACE inhibitor, ARB, or diuretic for hypertension 2, 9, 4
Hypothyroidism should be checked and treated with thyroxine replacement, as it is a reversible cause of bradycardia 1, 9, 5

The American College of Cardiology recommends directing therapy at eliminating the offending condition if a reversible cause is identified, which is a Class I recommendation 2, 9, 4
Permanent pacing is recommended when symptomatic bradycardia persists despite treating reversible causes, which is a Class I recommendation 2, 4

The American College of Cardiology states that permanent pacing causes harm in scenarios such as young individuals and well-conditioned athletes with resting heart rates <40 bpm due to elevated parasympathetic tone, and sleep-related bradycardia or pauses during sleep (Class III Harm) 3, 4

The American Heart Association warns against failing to identify reversible causes before pacemaker implantation, which is the most important clinical error and leads to unnecessary device complications 10, 8
Proceeding to pacemaker for sleep-related bradycardia without sleep apnea evaluation and CPAP trial is a critical pitfall to avoid 7
Implanting a pacemaker in asymptomatic patients is not recommended due to procedural complications and long-term lead management issues outweighing any benefit (Class III Harm) 3, 4